feed,title,long_url,short_url
Benzinga,BioLineRx Secures $40M In Debt Financing To Fund Commercialization Of Stem Cell Mobilization For Blood Cancer,https://benzinga.com/general/biotech/22/09/28885279/biolinerx-secures-40m-in-debt-financing-to-fund-commercialization-of-stem-cell-mobilization-for-b,https://bit.ly/3LgCMBU
